148 related articles for article (PubMed ID: 36810164)
1. Levels of Soluble Interleukin 6 Receptor and Asp358Ala Are Associated With Cognitive Performance and Alzheimer Disease Biomarkers.
Quillen D; Hughes TM; Craft S; Howard T; Register T; Suerken C; Hawkins GA; Milligan C
Neurol Neuroimmunol Neuroinflamm; 2023 May; 10(3):. PubMed ID: 36810164
[TBL] [Abstract][Full Text] [Related]
2. IL6 receptor
Wosiski-Kuhn M; Robinson M; Strupe J; Arounleut P; Martin M; Caress J; Cartwright M; Bowser R; Cudkowicz M; Langefeld C; Hawkins GA; Milligan C
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):e631. PubMed ID: 31611269
[TBL] [Abstract][Full Text] [Related]
3. Expression of Interleukin 6 signaling receptors in carotid atherosclerosis.
Ziegler L; Lundqvist J; Dreij K; Wallén H; de Faire U; Paulsson-Berne G; Hedin U; Matic L; Gigante B
Vasc Med; 2021 Feb; 26(1):3-10. PubMed ID: 33350884
[TBL] [Abstract][Full Text] [Related]
4. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the cognition-related pathogenic proteins in plasma neuronal-derived exosomes among normal cognitive adults over 45 years old with olfactory dysfunction.
Chen Z; Chang F; Yao L; Yuan F; Hong J; Wu D; Wei Y
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3467-3476. PubMed ID: 34693486
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 trans-signalling and risk of future cardiovascular events.
Ziegler L; Gajulapuri A; Frumento P; Bonomi A; Wallén H; de Faire U; Rose-John S; Gigante B
Cardiovasc Res; 2019 Jan; 115(1):213-221. PubMed ID: 30052808
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.
Chalaris A; Rabe B; Paliga K; Lange H; Laskay T; Fielding CA; Jones SA; Rose-John S; Scheller J
Blood; 2007 Sep; 110(6):1748-55. PubMed ID: 17567983
[TBL] [Abstract][Full Text] [Related]
8. Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration.
Ortner M; Goldhardt O; Diehl-Schmid J; Yakushev I; Lanz K; Hedderich DM; Manuilova E; Simon M; Weinberger JP; Grimmer T
J Prev Alzheimers Dis; 2022; 9(3):491-498. PubMed ID: 35841250
[TBL] [Abstract][Full Text] [Related]
9. Family-based association study of interleukin 6 (IL6) and its receptor (IL6R) functional polymorphisms in schizophrenia in the Polish population.
Kapelski P; Skibinska M; Maciukiewicz M; Pawlak J; Permoda-Osip A; Twarowska-Hauser J
J Neuroimmunol; 2015 Aug; 285():62-7. PubMed ID: 26198920
[TBL] [Abstract][Full Text] [Related]
10. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
[TBL] [Abstract][Full Text] [Related]
11. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
[TBL] [Abstract][Full Text] [Related]
12. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
[TBL] [Abstract][Full Text] [Related]
13. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
14. Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort.
Khandaker GM; Zammit S; Burgess S; Lewis G; Jones PB
Brain Behav Immun; 2018 Mar; 69():264-272. PubMed ID: 29197507
[TBL] [Abstract][Full Text] [Related]
15. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
[TBL] [Abstract][Full Text] [Related]
16. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Olsson B; Lautner R; Andreasson U; Öhrfelt A; Portelius E; Bjerke M; Hölttä M; Rosén C; Olsson C; Strobel G; Wu E; Dakin K; Petzold M; Blennow K; Zetterberg H
Lancet Neurol; 2016 Jun; 15(7):673-684. PubMed ID: 27068280
[TBL] [Abstract][Full Text] [Related]
17. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
19. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
Brosseron F; Maass A; Kleineidam L; Ravichandran KA; Kolbe CC; Wolfsgruber S; Santarelli F; Häsler LM; McManus R; Ising C; Röske S; Peters O; Cosma NC; Schneider LS; Wang X; Priller J; Spruth EJ; Altenstein S; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Buerger K; Janowitz D; Dichgans M; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Görß D; Laske C; Munk MH; Düzel E; Yakupow R; Dobisch L; Metzger CD; Glanz W; Ewers M; Dechent P; Haynes JD; Scheffler K; Roy N; Rostamzadeh A; Spottke A; Ramirez A; Mengel D; Synofzik M; Jucker M; Latz E; Jessen F; Wagner M; Heneka MT;
Alzheimers Res Ther; 2023 Jan; 15(1):13. PubMed ID: 36631909
[TBL] [Abstract][Full Text] [Related]
20. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.
Chen YH; Lin RR; Huang HF; Xue YY; Tao QQ
Front Aging Neurosci; 2022; 14():848180. PubMed ID: 35847667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
